TANC2
protein-codingtetratricopeptide repeat, ankyrin repeat and coiled-coil containing 2, the group of Tetratricopeptide repeat domain containing|Ankyrin repeat domain containing
Gene summary
Predicted to be a structural constituent of postsynaptic density. Predicted to be involved in dense core granule cytoskeletal transport; regulation of dendritic spine development; and regulation of dendritic spine morphogenesis. Predicted to act upstream of or within in utero embryonic development. Located in dendritic spine. Implicated in intellectual developmental disorder with autistic features and language delay, with or without seizures. [provided by Alliance of Genome Resources, Jul 2025]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~461.5 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AD
Disease ID:MONDO:0030051
Submitter: PanelApp Australia
Inheritance Pattern: AD
Disease ID:MONDO:0030051
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AD
Disease ID:MONDO:0030051
Submitter: Illumina
Inheritance Pattern: AD
Disease ID:MONDO:0030051
Submitter: G2P
Inheritance Pattern: AD
Disease ID:MONDO:0030051
Submitter: ClinGen
*TANC2* encodes a synaptic scaffolding protein that interacts with multiple postsynaptic density proteins in dendrites. *TANC2* was first reported in relation to autosomal dominant intellectual developmental disorder with autistic features and language delay, with or without seizures in 2019 (Guo et al., PMID: 31616000). Pediatric patients present with delayed language and motor development, intellectual disability, autism, and variable epilepsy and facial dysmorphic features. Psychiatric disorders and behavioral problems were common in adult probands or carrier parents. Twenty-one loss-of-function variants (frameshift, nonsense, splice, and exon deletion) that have been reported in 22 probands in 4 publications (PMIDs: 31616000, 33160097, 34861844, 40110879) are included in this curation. Most variants occurred *de novo*, but some individuals inherited the variant from an affected parent. More evidence is available in the literature, but the maximum score for genetic evidence (12 points) has been reached. *De novo* missense variants in *TANC2* have been observed in individuals with neurodevelopmental disorders (PMIDs: 31616000, 40110879); however, these variants were not scored due to lack of experimental evidence of gene impact. *TANC2* is highly constrained for truncating variants (pLI = 1, LOEUF = 0.17, gnomAD v4.1.1) and also exhibits constraint for missense variants (Z score = 4.01). The mechanism of pathogenicity is haploinsufficiency. This gene-disease relationship is also supported by experimental evidence, including a mouse model, protein interactions, and *in vitro* functional assays. In summary, there is definitive evidence supporting the relationship between *TANC2* and autosomal dominant intellectual developmental disorder with autistic features and language delay, with or without seizures. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time. This gene-disease pair was originally evaluated by the ClinGen Intellectual Disability and Autism Gene Curation Expert Panel on September 7, 2022. It was reevaluated on June 22, 2026 (SOP Version 12). Although additional cases were added, the classification did not change.
Inheritance Pattern: AD
Disease ID:MONDO:0000508
Submitter: Orphanet
Inheritance Pattern: AD
Disease ID:MONDO:0030051
Submitter: Ambry Genetics
Clinical Genomic Database (CGD)
Manifestation: Craniofacial; Neurologic
Intervention: General
Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to TANC2 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_001394998.1. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 1 | 11 | 82 | 4 | 98 | |
| missense | 1 | 503 | 60 | 1 | 565 | |
| nonsense | 10 | 10 | 5 | 25 | ||
| start loss | 1 | 1 | ||||
| frameshift | 7 | 17 | 7 | 31 | ||
| splice donor/acceptor (+/-2bp) | 5 | 9 | 5 | 19 | ||
| Total | 22 | 38 | 532 | 142 | 5 | 739 |
Highest pathogenic variant AF is 0.0000037300535
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_001381927.1 | 27 | MANE Select | |
| Ensembl | ENSP00000510600.1 | 27 | MANE Select | |
| RefSeq | NP_001398005.1 | 26 | Standard | |
| RefSeq | NP_079461.2 | 25 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Biological Process
- in utero embryonic development
Cellular Component
- glutamatergic synapse
- postsynaptic density, intracellular component
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000424789
- Coding exons
- 25
- Length
- 418144
- Individuals with no LoFs
- 124628
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 15
- Defined
- 124643
- p
- 0.0000602
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 2.34 | 900 | 1.12e+3 | 0.803 | 0.0000648 | 12872 |
| Missense (PolyPhen) | 179 | 314.61 | 0.56895 | 3540 | ||
| Synonymous | 0.864 | 400 | 423 | 0.947 | 0.0000244 | 4060 |
| Loss of Function | 8.09 | 8 | 91.5 | 0.0874 | 0.00000548 | 1002 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00013 | 0.00013 | rare |
| Latino/Admixed American | 0.000030 | 0.000029 | rare |
| Ashkenazi Jewish | 0.00011 | 0.000099 | rare |
| East Asian | 0.000056 | 0.000056 | rare |
| Finnish | 0 | 0.0 | absent |
| European (Non-Finnish) | 0.000082 | 0.000080 | rare |
| South Asian | 0.000033 | 0.000033 | rare |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
- Disease
- DISEASE: Note=Defects in TANC2 has been found in a patient with isolated coloboma, a defect of the eye characterized by the absence of ocular structures due to abnormal morphogenesis of the optic cup and stalk, and the fusion of the fetal fissure (optic fissure). Isolated colobomas may be associated with an abnormally small eye (microphthalmia) or small cornea. {ECO:0000269|PubMed:28493397}.;
Recessive Scores
- pRec
- 0.114
Intolerance Scores
- LoFtool
- 0.262
- RVIS EVS
- -2.78
- RVIS percentile EVS
- 0.67
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- N
- Indispensability score
- 0.219
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |